Currently, theyre only indicated for diabetes, weight loss, and the prevention of major adverse cardiac events in patients who have atherosclerotic cardiovascular diseasebut the research shows significant benefit in chronic kidney disease, so I think thats probably on the horizon
However, the GLP-1R-expressing cell types that mediate these effects are not known, although recent studies showed atrial GLP-1R-mediated regulation of blood pressure in mice [11]
Standard laboratory panelsincluding complete blood counts (CBC), basic metabolic panels (BMP), comprehensive metabolic panels (CMP), and lipid profilesare not designed to detect or measure semaglutide levels
Still, theres no clinical evidence showing that different timing of injections can relieve symptoms
However, unlike their mammalian counterparts, TLR9 expression has not yet been reported on avian erythrocytes